![]() |
市場調查報告書
商品編碼
1828160
2025年全球脈動式血氧監測儀系統市場報告Pulse Oximeter Global Market Report 2025 |
||||||
近年來,脈動式血氧監測儀系統市場規模穩定成長,從2024年的26.4億美元增加到2025年的27.3億美元,複合年成長率為3.6%。預測期內的成長可歸因於老年人口的成長、呼吸系統疾病盛行率的上升、醫院和醫療基礎設施的發展、意識提升以及全球疫情的影響。
預計2029年,脈動式血氧監測儀系統市場規模將成長至34.8億美元,複合年成長率為6.2%。預測期內的成長可歸因於與穿戴式裝置的整合、全球健康危機防範、政府醫療保健計畫、健康和保健監測以及全球健康危機防範。預測期內的主要趨勢包括遠端醫療整合、技術進步、對居家醫療的重視、智慧功能和連接性以及針對慢性病的遠端患者監護。
脈動式血氧監測儀系統是一種非侵入式測量設備,可快速測量個人的功能性血氧飽和度 (SpO2),並有助於及早發現低氧血症。脈動式血氧監測儀系統的主要功能是無需針頭或採血即可快速評估人體的血氧飽和度。
脈動式血氧監測儀系統種類繁多,可滿足各種特定需求,包括指尖血氧儀、手持式血氧儀、腕戴式血氧儀、桌上型血氧儀和床邊血氧儀。指尖血氧儀的設計尤其方便佩戴在患者指尖,並融合了連網技術和傳統技術。這些設備經過編程,可同時適用於成人和兒童患者。目標終端使用者包括醫院、診所、門診手術中心和家庭醫療保健機構。
2025年美國關稅大幅上調及其引發的貿易摩擦對醫療設備產業產生了重大影響,尤其對影像處理設備、手術用不銹鋼和一次性塑膠等進口零件產生了重大影響。由於醫院和診所抵制漲價,製造商面臨利潤壓力。監管挑戰進一步加劇了形勢,因為由於關稅而更換供應商通常需要醫療設備重新認證,導致市場准入延遲。為此,企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快研發更具成本效益的材料來降低風險。
本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分,該系列提供脈動式血氧監測儀系統市場的統計數據,包括全球市場規模、各地區市場佔有率、競爭對手的脈動式血氧監測儀系統佔有率、脈動式血氧監測儀系統脈動式血氧監測儀系統。本脈動式血氧監測儀系統脈動式血氧監測儀系統研究報告對該行業的現狀和未來趨勢進行了詳細分析,為您提供所需的全面觀點。
未來五年的預測成長率為6.2%,較我們先前對該市場的預測略有下降0.3%。下降的主要原因是美國與其他國家之間關稅的影響。這將直接影響美國,導致光電二極體感測器和多波長發光二極體二極體(LED) 陣列的成本上升,這些產品主要從中國大陸和台灣進口,這可能會影響病患監測設備的供應。此外,由於互惠關稅以及貿易緊張局勢和限制加劇對全球經濟和貿易的負面影響,影響範圍也將更加廣泛。
呼吸系統疾病盛行率的上升預計將推動未來脈動式血氧監測儀系統市場的成長。呼吸系統疾病會影響呼吸道和肺部,進而影響人類呼吸。這種成長主要是由於空氣污染加劇、粉塵暴露、人口老化和吸煙習慣等因素造成的。脈動式血氧監測儀系統的價值在於它們可以在症狀變得明顯之前檢測到血氧飽和度水平的變化。例如,2023 年 12 月,美國政府機構國家生物技術資訊中心報告稱,預計 COPD 患者數量將增加 1.12 億,到 2050 年將達到總合億,佔受目標人口的 9.5%。因此,呼吸系統疾病盛行率的上升正在推動對脈動式血氧監測儀系統的需求。
遠端醫療和遠端醫療的擴展預計將在未來推動脈動式血氧監測儀系統市場的成長。遠端醫療包括使用通訊技術遠端提供各種醫療服務和訊息,而遠端醫療則具體指遠距臨床諮詢和醫療保健服務。脈動式血氧監測儀系統在評估遠端位置的氧氣水平方面發揮關鍵作用,這對於慢性病患者的家庭醫療保健尤其重要。脈動式血氧監測儀系統與穿戴式裝置和智慧型手機整合,可增強其在遠端醫療中的效用,並實現無縫資料共用。這種整合減少了去醫院就診的需要,因為患者可以在家中使用脈動式血氧監測儀系統並傳輸即時數據進行遠端評估。例如,美國政府機構疾病管制與預防中心在 2024 年 6 月報告稱,2022 年有 30.1% 的成年人在過去一年中使用過遠端醫療。因此,遠端醫療和遠端醫療的擴展正在推動脈動式血氧監測儀系統市場的成長。
脈動式血氧監測儀系統市場的主要企業專注於開發技術先進的解決方案,例如蜂窩連接脈動式血氧監測儀系統,以改善患者監測和數據收集。蜂窩連接脈動式血氧監測儀系統具有蜂窩連接功能,允許它們透過蜂巢式網路(例如 4G 和 5G)將數據無線傳輸到醫療保健提供者和雲端基礎的健康平台。例如,2024 年 8 月,美國遠端監控平台開發商 Prevounce Health LLC 推出了 Pylo OX1-LTE,這是一款專為遠端患者監護(RPM) 設計的蜂窩連接脈動式血氧監測儀系統。該設備針對患有慢性阻塞性肺病和氣喘等慢性呼吸系統疾病的患者以及受 COVID-19 影響的患者,提供可靠的蜂窩連接、準確的 SpO2 和脈搏率讀數,以及帶有明亮 OLED 螢幕的方便用戶使用型設計。它與 Prevounce 的遠端護理管理平台無縫整合,並可透過 Pylo Cloud API 連接到第三方健康軟體。
脈動式血氧監測儀系統市場的主要企業正在積極投資最尖端科技,例如脈搏血氧計(SpO2) 感測器技術,以增強其競爭地位。脈搏血氧計(SpO2) 感測器技術採用專門的感測器來測量血氧飽和度水平,通常稱為 SpO2。2022 年 11 月,美國病患監測解決方案公司 BioIntelliSense Inc. 推出了創新的脈搏血氧計(SpO2) 感測器技術,該技術可解決與皮膚色素沉著和運動監測相關的挑戰。這種取得專利的感測器晶片組和整合處理技術可確保在不同膚色和運動過程中達到臨床級的準確度。這項突破性技術旨在透過克服過去在活動和較深膚色期間的準確度問題來促進醫療保健公平。其設計結合了獨特的白光發送器和頻譜感測器,超越了傳統架構,可提供臨床精確的 SpO2 測量值。
2022年1月,美國輸液治療和重症加護專家ICU Medical完成了對史密斯醫療的收購,收購金額未揭露。這項策略性措施擴展了史密斯醫療的產品線,包括輸液幫浦、導管和一系列血管通路設備。史密斯醫療總部位於美國,專注於脈動式血氧監測儀系統等創新醫療產品,此次收購將為ICU Medical的產品組合增添寶貴的多樣性。
脈動式血氧監測儀系統市場的主要企業包括美敦力公司、通用電氣醫療集團、Masimo 公司、Nonin Medical 公司、日本光電公司、荷蘭皇家飛利浦公司、飛利浦醫療保健公司、Contec Medical Systems 公司、歐姆龍公司、Carefusion 公司、CAS Medical Systems 公司、Opto Circuits India 公司、歐姆龍公司、Carefusion 公司、CAS Medical Systems 公司、Opto Circuits India.公司、Beurer GmbH 公司、Dragerwerk AG &Co.KGaA 公司、ICU Medical 公司、Smiths Medical 公司、邁瑞醫療國際有限公司、Criticare Systems 公司、BPL Medical Technologies 公司、ChoiceMMed America 公司、北京 Choice 電子技術有限公司、Creative Medical 公司、Edan Instruments 公司、Heal Holdings、Peal Holdings 公司、Edan Force Instruments 公司。
2024 年,北美是脈動式血氧監測儀系統市場最大的地區。脈動式血氧監測儀系統市場報告涵蓋以下地區:亞太地區、西歐、中歐和東歐、北美、南美以及中東和非洲。
脈動式血氧監測儀系統市場報告涉及的國家有澳洲、巴西、中國、法國、德國、印度、印尼、日本、俄羅斯、韓國、英國、美國、加拿大、義大利和西班牙。
脈動式血氧監測儀系統市場涵蓋指尖脈動式血氧監測儀系統和血氧飽和度監測儀的銷售。該市場的價值指的是“出廠價”,即商品製造商或生產商銷售給其他營業單位(包括下游製造商、批發商、經銷商和零售商)或直接銷售給最終客戶的價值。該市場中的商品價值還包括商品製造商銷售的任何相關服務。
A pulse oximeter serves as a non-invasive measurement device that promptly gauges an individual's functional oxygen saturation (SpO2), facilitating early detection of hypoxemia. The primary functionality of a pulse oximeter is to swiftly assess oxygen saturation levels in the human body without the necessity for needles or blood samples.
Diverse categories of pulse oximeters cater to specific needs, including fingertip oximeters, handheld oximeters, wrist-worn oximeters, and table-top and bedside oximeters. Fingertip oximeters, specifically, are designed for convenient attachment to a patient's fingertip, incorporating a blend of connected and conventional technologies. These devices are programmed to cater to both adult and pediatric populations. Targeted end-users encompass hospitals and clinics, ambulatory surgical centers, and home healthcare settings.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.
The pulse oximeters market research report is one of a series of new reports from The Business Research Company that provides pulse oximeters market statistics, including pulse oximeters industry global market size, regional shares, competitors with a pulse oximeters market share, detailed pulse oximeters market segments, market trends and opportunities, and any further data you may need to thrive in the pulse oximeters industry. This pulse oximeters market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The pulse oximeter market size has grown steadily in recent years. It will grow from $2.64 billion in 2024 to $2.73 billion in 2025 at a compound annual growth rate (CAGR) of 3.6%. The growth in the historic period can be attributed to the increasing aging population, rise in respiratory diseases, hospital and healthcare infrastructure development, awareness and education, and global pandemic impact.
The pulse oximeter market size is expected to see strong growth in the next few years. It will grow to $3.48 billion in 2029 at a compound annual growth rate (CAGR) of 6.2%. The growth in the forecast period can be attributed to integration with wearable devices, global health crises preparedness, government healthcare initiatives, health and wellness monitoring, and global health crises preparedness. Major trends in the forecast period include telehealth integration, technological advancements, home healthcare emphasis, smart features and connectivity, and remote patient monitoring in chronic diseases.
The forecast of 6.2% growth over the next five years reflects a modest reduction of 0.3% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through higher expenses for photodiode sensors and multi-wavelength light-emitting diode (LED) arrays, largely imported from China and Taiwan, affecting patient monitoring equipment availability.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The rising prevalence of respiratory diseases is projected to drive growth in the pulse oximeter market in the future. Respiratory diseases are conditions affecting the airways and lungs, which impact human respiration. This increase is largely attributed to factors such as growing air pollution, dust exposure, an aging population, and smoking habits. Pulse oximeters are valuable in detecting changes in oxygen saturation levels before symptoms become noticeable. For example, in December 2023, the National Center for Biotechnology Information, a US-based government agency, reported that cases of COPD are expected to rise by 112 million, reaching a total of 592 million by 2050, representing 9.5% of the eligible population. Consequently, the growing prevalence of respiratory diseases is driving the demand for pulse oximeters.
The growing expansion of telehealth and telemedicine is expected to drive the growth of the pulse oximeter market in the future. Telehealth encompasses the use of telecommunications technology to deliver a variety of healthcare services and information remotely, while telemedicine specifically refers to remote clinical consultations and healthcare delivery. Pulse oximeters play a vital role in assessing oxygen levels from a distance, which is particularly important for at-home healthcare, especially for patients with chronic conditions. The integration of pulse oximeters with wearables and smartphones enhances their utility in telehealth, enabling seamless data sharing. This integration reduces the necessity for hospital visits, as patients can use pulse oximeters at home to transmit real-time data for remote evaluation. For instance, in June 2024, the Centers for Disease Control and Prevention, a US-based government agency, reported that in 2022, 30.1% of adults had used telemedicine in the past year. Therefore, the increasing expansion of telehealth and telemedicine is driving the growth of the pulse oximeter market.
Major companies in the pulse oximeter market are concentrating on developing technologically advanced solutions, such as cellular-connected pulse oximeters, to improve patient monitoring and data collection. A cellular-connected pulse oximeter is equipped with cellular connectivity features, enabling it to transmit data wirelessly over cellular networks (like 4G or 5G) to healthcare providers or cloud-based health platforms. For example, in August 2024, Prevounce Health LLC, a US-based developer of a remote monitoring platform, launched the Pylo OX1-LTE, a cellular-connected pulse oximeter specifically designed for remote patient monitoring (RPM). Aimed at patients with chronic respiratory conditions such as COPD and asthma, as well as those impacted by COVID-19, the device offers reliable cellular connectivity, accurate SpO2 and pulse rate readings, and a user-friendly design with a bright OLED screen. It integrates seamlessly with Prevounce's remote care management platform and can connect to third-party health software via the Pylo cloud API.
Prominent companies in the pulse oximeter market are actively investing in cutting-edge technologies, such as Pulse Oximetry (SpO2) Sensor Technology, to gain a competitive edge. Pulse Oximetry (SpO2) Sensor Technology employs specialized sensors to measure oxygen saturation levels in the blood, commonly expressed as SpO2. In November 2022, BioIntelliSense Inc., a US-based patient monitoring solutions company, introduced innovative pulse oximetry (SpO2) sensor technology addressing challenges related to skin pigmentation and motion monitoring. This patented sensor chipset and integrated processing technology ensure medical-grade accuracy, even across diverse skin tones and during movement. This breakthrough technology aims to contribute to healthcare equity by overcoming historical accuracy issues during activity and with darker skin tones. The design incorporates a unique white light emitter and spectral sensor, surpassing traditional architectures and providing clinically accurate SpO2 measurements.
In January 2022, ICU Medical, a US-based specialist in infusion therapy and critical care, completed the acquisition of Smiths Medical for an undisclosed amount. This strategic move enables ICU Medical to expand its product line with Smiths Medical's offerings, including infusion pumps, catheters, and various vascular access equipment. Smiths Medical, a US-based company specializing in innovative medical products, including pulse oximeters, adds valuable diversity to ICU Medical's portfolio through this acquisition.
Major companies operating in the pulse oximeter market include Medtronic Plc, GE Healthcare, Masimo Corporation, Nonin Medical Inc., Nihon Kohden Corporation, Koninklijke Philips NV, Philips Healthcare, Contec Medical Systems Co. Ltd., Omron Corporation, Carefusion Corp., CAS Medical Systems Inc., Opto Circuits India Ltd., Welch Allyn Inc., Spacelabs Healthcare, Meditech Equipment Co. Ltd., Vyaire Medical Inc., Beurer GmbH, Dragerwerk AG & Co. KGaA, ICU Medical Inc., Smiths Medical, Mindray Medical International Limited, Criticare Systems Inc., BPL Medical Technologies, ChoiceMMed America Co. Ltd., Beijing Choice Electronic Technology Co. Ltd., Creative Medical, Edan Instruments Inc., Heal Force Bio-Meditech Holdings Limited, Mediana Co. Ltd., Medlab Clinical Ltd.
North America was the largest region in the pulse oximeter market in 2024. The regions covered in the pulse oximeter market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the pulse oximeter market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The pulse oximeter market consists of sales of finger-tip pulse oximeter, blood oxygen saturation monitor. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Pulse Oximeter Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on pulse oximeter market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for pulse oximeter ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The pulse oximeter market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.